Meet the Authors

Emily Phillips

Principal, Market Access

Part 2: Addressing the Unique Aspects of Rare Disease Product Commercialization

Launching Expensive Therapy with Limited Budget (VIDEO)

This video highlights the challenges of launching an expensive therapy for a rare disease with a limited budget. It emphasizes the importance of partnerships with healthcare providers, specialty pharmacies, and patient support programs to overcome access barriers and ensure effective treatment. Strategic planning, tailored care, and efficient resource allocation are key to successful implementation.

Presenters

More Expert Conversation Videos

Special Considerations for First-to-Market (VIDEO)
The video highlights the crucial role of advocacy groups and the importance of early, strategic planning for successfully launching rare disease treatments.

Navigating success during a rare disease product launch (VIDEO)
Explore insights on successfully launching products in rare disease markets, with a focus on key success factors and best practices.

Watch the full Fierce Biotech presentation:

Addressing the Unique Aspects of Rare Disease Product Commercialization

Meet the Authors

Emily Phillips

Principal, Market Access

Let's Talk

Herspiegel is a leading professional services firm helping biotech start-ups and the world’s largest pharmaceutical companies navigate the path from science to brand performance and change patients’ lives. We are committed to using strategic insights from medical to commercial to market access to solve critical problems.